{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:34:43Z","timestamp":1761597283507},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbrc.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T01:06:39Z","timestamp":1308445599000},"page":"494-500","source":"Crossref","is-referenced-by-count":23,"title":["The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment"],"prefix":"10.1016","volume":"410","author":[{"given":"Benjamin B.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Tancredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott I.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent E.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"viii","key":"10.1016\/j.bbrc.2011.06.008_b0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0095-5108(05)70047-6","article-title":"Infection, neutrophils, and hematopoietic growth factors in the pathogenesis of neonatal chronic lung disease","volume":"27","author":"Papoff","year":"2000","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.moh.0000190113.31027.d5","article-title":"Neutrophil granule contents in the pathogenesis of lung injury","volume":"13","author":"Moraes","year":"2006","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0185","doi-asserted-by":"crossref","first-page":"28156","DOI":"10.1074\/jbc.M109.054759","article-title":"Inhibition of the soluble epoxide hydrolase by tyrosine nitration","volume":"284","author":"Barbosa-Sicard","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.06.008_b0190","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.lfs.2006.07.031","article-title":"Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain","volume":"79","author":"Inceoglu","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2011.06.008_b0195","doi-asserted-by":"crossref","first-page":"18901","DOI":"10.1073\/pnas.0809765105","article-title":"Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways","volume":"105","author":"Inceoglu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.008_b0200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1476-5381.2008.00009.x","article-title":"Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation","volume":"156","author":"Liu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0210","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/1535-7163.MCT-09-0119","article-title":"Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo","volume":"8","author":"Liu","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2011.06.008_b0215","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: the role of PPARgamma epoxyeicosatrienoic acids and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.008_b0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","author":"Schmelzer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.008_b0220","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1073\/pnas.0605908103","article-title":"Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors","volume":"103","author":"Schmelzer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.008_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000159080","article-title":"Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone","volume":"32","author":"Harder","year":"1995","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.bbrc.2011.06.008_b0065","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2011.06.008_b0070","doi-asserted-by":"crossref","first-page":"15334","DOI":"10.1016\/S0021-9258(18)66872-3","article-title":"Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry","volume":"261","author":"Fitzpatrick","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.06.008_b0075","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/S0021-9258(18)53266-X","article-title":"Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase","volume":"268","author":"Zeldin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.06.008_b0080","first-page":"H2113","article-title":"14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells","volume":"275","author":"Fang","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0225","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0891-5849(02)01003-1","article-title":"Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant","volume":"33","author":"Smith","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2011.06.008_b0090","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.0409591102","article-title":"Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.008_b0230","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/carcin\/bgi189","article-title":"MAPK\/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats","volume":"26","author":"Zhong","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2011.06.008_b0235","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/08958370701861538","article-title":"Acute tobacco smoke-induced airways inflammation in spontaneously hypertensive rats","volume":"20","author":"Yu","year":"2008","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1465-9921-10-118","article-title":"Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats","volume":"10","author":"Bolton","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbrc.2011.06.008_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08958379409029697","article-title":"Sidestream cigarette-smoke generation and exposure system for environmental tobacco-smoke studies","volume":"6","author":"Teague","year":"1994","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb\/8.1.9","article-title":"Differentiation-related expression of ICAM-1 by rat alveolar epithelial cells","volume":"8","author":"Christensen","year":"1993","journal-title":"Am. J. Respir. Cell. Mol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0120","doi-asserted-by":"crossref","first-page":"L180","DOI":"10.1152\/ajplung.00430.2001","article-title":"ICAM-1 facilitates alveolar macrophage phagocytic activity through effects on migration over the AEC surface","volume":"283","author":"Paine","year":"2002","journal-title":"Am. J. Physiol.-Lung C"},{"key":"10.1016\/j.bbrc.2011.06.008_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/taap.1997.8197","article-title":"Cytotoxicity of linoleic acid diols to renal proximal tubular cells","volume":"146","author":"Moran","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/taap.2000.9053","article-title":"Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s","volume":"168","author":"Moran","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/tx000200o","article-title":"Defining mechanisms of toxicity for linoleic acid monoepoxides and diols in Sf-21 cells","volume":"14","author":"Moran","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/taap.2001.9149","article-title":"Analysis of the toxic effects of linoleic acid, 12,13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria","volume":"172","author":"Moran","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-4274(01)00463-5","article-title":"Linoleic acid cis-epoxyoctadecenoic acids and dihydroxyoctadecadienoic acids are toxic to Sf-21 cells in the absence of albumin","volume":"126","author":"Mitchell","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2011.06.008_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.toxlet.2003.11.002","article-title":"Linoleic acid epoxide promotes the maintenance of mitochondrial function and active Na+ transport following hypoxia","volume":"147","author":"Nowak","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2011.06.008_b0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1113\/jphysiol.2010.199505","article-title":"Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension","volume":"589","author":"Honetschlagerova","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/CS20080039","article-title":"Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats","volume":"116","author":"Olearczyk","year":"2009","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.bbrc.2011.06.008_b0255","doi-asserted-by":"crossref","first-page":"F342","DOI":"10.1152\/ajprenal.00004.2007","article-title":"Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats","volume":"293","author":"Huang","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0260","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2011.06.008_b0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/FJC.0b013e3182055baf","article-title":"Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene","volume":"57","author":"Aboutabl","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0270","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/ATVBAHA.109.186064","article-title":"and dyslipidemia","volume":"29","author":"Zhang","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.008_b0280","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.06.008_b0285","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11009661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11009661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T21:12:59Z","timestamp":1637874779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11009661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0006291X11009661"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.06.008","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}